Explore Watchlists Pricing

EAGLE PHARMACEUTICALS, INC. (EGRX) Balance sheet

Market cap

$4.94M

P/E ratio

0.5x

Summary Financials

Income statement Balance sheet Cash flow Other

	2014/09	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12
Cash and cash equivalents	23	79	53	115	79	110	103	98	55
Total cash & short-term investments	23	79	53	115	79	110	103	98	55
Accounts receivable, net	7	26	42	54	66	48	51	41	72
Inventories	1	15	3	5	8	7	8	22	48
Total current assets	53	122	109	189	164	179	166	173	189
Property, plant and equipment, net	0	2	3	7	2	2	2	2	1
Total assets	53	125	214	270	239	255	253	254	406
Accounts payable	4	4	15	12	10	5	6	16	19
Long-term debt, current	-	-	-	5	6	5	8	26	6
Total current liabilities	20	34	41	47	40	39	38	74	111
Long-term debt, non-current	-	-	-	43	38	34	25	-	56
Total liabilities	-	-	-	-	-	75	67	77	173
Retained earnings	-104	-107	-26	26	58	73	84	76	112
Stockholders' equity	33	90	151	179	161	179	186	176	234
Working capital